News FocusTHOMAS MONATH PROFILE

Riding the Biodefense Wave

Science  15 Aug 2003:
Vol. 301, Issue 5635, pp. 912-913
DOI: 10.1126/science.301.5635.912

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

CAMBRIDGE, MASSACHUSETTS-- An infectious disease researcher-turned-entrepreneur has used strong scientific credentials, an aversion to risk, a stroke of luck, and enviable connections to turn a company on the verge of collapse into a profitable producer of biodefense vaccines.

Related Content